MicuRx Pharmaceuticals Company
MicuRx discovers and develops novel antibiotics to prevent and treat drug-resistant bacterial infections.
Technology:
Small Molecules
Industry:
PharmTech
Headquarters:
Hayward, California, United States
Founded Date:
2007
Employees Number:
11-50
Funding Status:
Late Stage Venture
Estimated Revenue:
$10M to $50M
Register and Claim Ownership